Publications
302
Citations
8,064
Est. group size
~2
Recurring co-author estimate
Active years
44
Publishing since 1983
Typically publishes in teams of ~7 · 6% small-team papers (≤3 authors) · across 68 venues
- Early-age efferocytosis directs macrophage arachidonic acid metabolism for tissue regeneration
Immunity · 2025
- Effect of vardenafil in long-standing diabetic patients comparing different doses regarding erectile dysfunction, testosterone level and partner satisfaction
Arab Journal of Urology · 2025
- Autotaxin Inhibition Reduces Post‐Ischemic Myocardial Inflammation via Epigenetic Gene Modifications
Stem Cell Reviews and Reports · 2024
- Regional End-Systolic Circumferential Strain Demonstrates Reduced Function in Remote Myocardium after Anterior STEMI
arXiv (Cornell University) · 2024
- Hydrotherapy to Hospice: The Hidden Perils of Necrotizing Fasciitis Mimicry in Elderly Patients
Cureus · 2024
- A Case of an Intrathoracic Accessory Rib Revealed on Chest X-ray
Cureus · 2024
- Prognostic Significance of Activated Monocytes in Patients with ST-Elevation Myocardial Infarction
International Journal of Molecular Sciences · 2023
- Data Supplement from Bioactive Lipids, LPC and LPA, Are Novel Prometastatic Factors and Their Tissue Levels Increase in Response to Radio/Chemotherapy
2023
- Data Supplement from Bioactive Lipids, LPC and LPA, Are Novel Prometastatic Factors and Their Tissue Levels Increase in Response to Radio/Chemotherapy
2023
- Data Supplement from Bioactive Lipids, LPC and LPA, Are Novel Prometastatic Factors and Their Tissue Levels Increase in Response to Radio/Chemotherapy
2023
- Data Supplement from Bioactive Lipids, LPC and LPA, Are Novel Prometastatic Factors and Their Tissue Levels Increase in Response to Radio/Chemotherapy
2023
- Data Supplement from Bioactive Lipids, LPC and LPA, Are Novel Prometastatic Factors and Their Tissue Levels Increase in Response to Radio/Chemotherapy
2023
- Data from Bioactive Lipids, LPC and LPA, Are Novel Prometastatic Factors and Their Tissue Levels Increase in Response to Radio/Chemotherapy
2023
- Data from Bioactive Lipids S1P and C1P Are Prometastatic Factors in Human Rhabdomyosarcoma, and Their Tissue Levels Increase in Response to Radio/Chemotherapy
2023
- Data from Bioactive Lipids S1P and C1P Are Prometastatic Factors in Human Rhabdomyosarcoma, and Their Tissue Levels Increase in Response to Radio/Chemotherapy
2023
- Circulation×16
- Journal of the American College of Cardiology×16
- Stem Cell Reviews and Reports×12
- Angiology×7
- The American Journal of Cardiology×7
- Yi Li
Medicine · University of Michigan
- Shreeya Bakshi
Medicine · University of Michigan
- Dinesh Bharti
Medicine · Indiana University
- Troy A. Markel
Medicine · Indiana University
- Michael Sorkin
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile